BST1 and ovarian carcinoma: The implication of CD157 in tumor cell motility and invasiveness, and its association with poor outcome in ovarian cancer patients, prompted us to further investigate its biological role in EOC progression using engineered ovarian cancer cell lines as an experimental model.